Chemotherapy for Klatskin's Tumor
|4,703 Patients Studied||41 Studies (View)|
Definition: An adjuvant is a pharmacological or immunological agent that modifies the effect of other agents, such as a drug or vaccine, while having few if any direct effects when given by itself. They are often included in vaccines to enhance the recipient's immune response to a supplied antigen, while keeping the injected foreign material to a minimum. A Klatskin tumor (or hilar cholangiocarcinoma) is a cholangiocarcinoma occurring at the confluence of the right and left hepatic bile ducts. It is named after Dr Gerald Klatskin, an American physician working at Yale. (SOURCE: Wikipedia)
Where does Chemotherapy rank compared to other Klatskin's Tumor treatments?
Most Researched Conditions
What other conditions have been studied?
Health experts published 41 studies on Chemotherapy for Extrahepatic Bile Duct Adenocarcinoma patients suffering from Klatskin's Tumor.
Most Discussed Conditions
What conditions are patients discussing?
What treatments have patients discontinued using?
What treatments are patients switching to?